Company Filing History:
6 out of 2,103 
1 out of 90 
1 out of 19 Years Active: 2004-2020
Title: Innovations in Retinal Disease Treatment by Thomas A Reh
Introduction
Thomas A Reh is a prominent inventor based in Seattle, WA, known for his significant contributions to the field of retinal disease treatment. With a total of seven patents to his name, Reh has focused on innovative methods that aim to improve the lives of individuals suffering from retinal conditions.
Latest Patents
Reh's latest patents include groundbreaking methods for the treatment of retinal disease through photoreceptor gene expression modulation. These patents detail various techniques for decreasing rod gene expression in the retina. They also cover methods for reducing the protein products expressed by rod genes in the retina. Furthermore, his work includes strategies for treating diseases or conditions that can be addressed by decreasing rod gene expression or their protein products in the retina. His innovative approaches aim to provide effective treatments for retinal diseases in affected subjects.
Career Highlights
Throughout his career, Thomas A Reh has worked with esteemed organizations such as the University of Washington and Acorda Therapeutics, Inc. His experience in these institutions has allowed him to advance his research and develop impactful solutions for retinal diseases.
Collaborations
Reh has collaborated with notable colleagues, including Paul Nakamura and Sheng Ding. These partnerships have contributed to the advancement of his research and the development of his patented methods.
Conclusion
Thomas A Reh's work in the field of retinal disease treatment showcases his dedication to innovation and improving patient outcomes. His patents reflect a commitment to advancing medical science and providing hope for those affected by retinal conditions.